Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore A Bass

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Thrombosis and Haemostasis|October 28, 2016
Impact of chronic kidney disease on platelet P2Y<sub>12</sub> receptor signalling in patients with type 2 diabetes mellitusLydia R Engwenyu, Francesco Franchi, Fabiana Rollini, et al.
European Heart Journal|June 24, 2008
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 studyDominick J Angiolillo, Piera Capranzano, Shinya Goto, et al.
Journal of Thrombosis and Thrombolysis|November 28, 2012
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigationJosé L Ferreiro, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Journal of the American College of Cardiology|September 19, 2006
Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome studyHideki Futamatsu, Manel Sabaté, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions|November 5, 2021
Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With CangrelorFrancesco Franchi, Fabiana Rollini, Mattia Galli, et al.
The American Journal of Cardiology|December 27, 2005
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary interventionDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of the American College of Cardiology|September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery diseaseDominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.
Journal of the American College of Cardiology|July 18, 2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentDominick J Angiolillo, Esther Bernardo, Celia Ramírez, et al.
Thrombosis and Haemostasis|December 4, 2015
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled studyFrancesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Thrombosis and Haemostasis|October 28, 2016
Impact of chronic kidney disease on platelet P2Y<sub>12</sub> receptor signalling in patients with type 2 diabetes mellitusLydia R Engwenyu, Francesco Franchi, Fabiana Rollini, et al.
European Heart Journal|June 24, 2008
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 studyDominick J Angiolillo, Piera Capranzano, Shinya Goto, et al.
Journal of Thrombosis and Thrombolysis|November 28, 2012
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigationJosé L Ferreiro, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Journal of the American College of Cardiology|September 19, 2006
Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome studyHideki Futamatsu, Manel Sabaté, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions|November 5, 2021
Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With CangrelorFrancesco Franchi, Fabiana Rollini, Mattia Galli, et al.
The American Journal of Cardiology|December 27, 2005
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary interventionDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of the American College of Cardiology|September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery diseaseDominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.
Journal of the American College of Cardiology|July 18, 2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentDominick J Angiolillo, Esther Bernardo, Celia Ramírez, et al.
Thrombosis and Haemostasis|December 4, 2015
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled studyFrancesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
Pageof 14